AIM logo

AIM ImmunoTech (AIM) Company Overview

Profile

Full Name:

AIM ImmunoTech Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 12, 1996

Indexes:

Not included

Description:

AIM ImmunoTech is a biotechnology company focused on developing innovative therapies for cancer and viral diseases. They work on treatments that enhance the immune system's ability to fight diseases, aiming to improve patient outcomes and quality of life through advanced medical research and development.

Key Details

Price

$0.13

Annual Revenue

$202.00 K(+43.26% YoY)

Annual EPS

-$0.60(-50.00% YoY)

Annual ROE

-118.94%

Beta

0.77

Events Calendar

Earnings

Next earnings date:

May 16, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Apr 2, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 11, 2019

Analyst ratings

Recent major analysts updates

Dec 10, 24 Ascendiant Capital
Buy
Oct 22, 24 Maxim Group
Buy
Sep 3, 24 Ascendiant Capital
Buy
Oct 10, 19 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for AIM ImmunoTech?
  • Does AIM ImmunoTech pay dividends?
  • What sector is AIM ImmunoTech in?
  • What industry is AIM ImmunoTech in?
  • What country is AIM ImmunoTech based in?
  • When did AIM ImmunoTech go public?
  • Is AIM ImmunoTech in the S&P 500?
  • Is AIM ImmunoTech in the NASDAQ 100?
  • Is AIM ImmunoTech in the Dow Jones?
  • When was AIM ImmunoTech's last earnings report?
  • When does AIM ImmunoTech report earnings?
  • Should I buy AIM ImmunoTech stock now?

What is the ticker symbol for AIM ImmunoTech?

The ticker symbol for AIM ImmunoTech is NYSE American:AIM

Does AIM ImmunoTech pay dividends?

No, AIM ImmunoTech does not pay dividends

What sector is AIM ImmunoTech in?

AIM ImmunoTech is in the Healthcare sector

What industry is AIM ImmunoTech in?

AIM ImmunoTech is in the Biotechnology industry

What country is AIM ImmunoTech based in?

AIM ImmunoTech is headquartered in United States

When did AIM ImmunoTech go public?

AIM ImmunoTech's initial public offering (IPO) was on July 12, 1996

Is AIM ImmunoTech in the S&P 500?

No, AIM ImmunoTech is not included in the S&P 500 index

Is AIM ImmunoTech in the NASDAQ 100?

No, AIM ImmunoTech is not included in the NASDAQ 100 index

Is AIM ImmunoTech in the Dow Jones?

No, AIM ImmunoTech is not included in the Dow Jones index

When was AIM ImmunoTech's last earnings report?

AIM ImmunoTech's most recent earnings report was on Nov 15, 2024

When does AIM ImmunoTech report earnings?

The next expected earnings date for AIM ImmunoTech is May 16, 2025

Should I buy AIM ImmunoTech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions